4.7 Article

Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 173, Issue 5, Pages 870-887

Publisher

WILEY
DOI: 10.1111/bph.13399

Keywords

-

Funding

  1. British Heart Foundation [RG06/008/22062]
  2. Department of Cardiovascular Sciences, University of Leicester
  3. van Geest Heart and Cardiovascular Diseases Research Fund
  4. British Heart Foundation [RG/06/008/22062] Funding Source: researchfish

Ask authors/readers for more resources

Background and PurposeWe investigated the hypothesis that elevated glucose increases contractile responses in vascular smooth muscle and that this enhanced constriction occurs due to the glucose-induced PKC-dependent inhibition of voltage-gated potassium channels. Experimental ApproachPatch-clamp electrophysiology in rat isolated mesenteric arterial myocytes was performed to investigate the glucose-induced inhibition of voltage-gated potassium (K-v) current. To determine the effects of glucose in whole vessel, wire myography was performed in rat mesenteric, porcine coronary and human internal mammary arteries. Key ResultsGlucose-induced inhibition of K-v was PKC-dependent and could be pharmacologically dissected using PKC isoenzyme-specific inhibitors to reveal a PKC-dependent component of K-v inhibition dominating between 0 and 10mM glucose with an additional PKC-dependent component becoming evident at concentrations greater than 10mM. These findings were supported using wire myography in all artery types used, where contractile responses to vessel depolarization and vasoconstrictors were enhanced by increasing bathing glucose concentration, again with evidence for distinct and complementary PKC/PKC-mediated components. Conclusions and ImplicationsOur results provide compelling evidence that glucose-induced PKC/PKC-mediated inhibition of K-v current in vascular smooth muscle causes an enhanced constrictor response. Inhibition of K-v current causes a significant depolarization of vascular myocytes leading to marked vasoconstriction. The PKC dependence of this enhanced constrictor response may present a potential therapeutic target for improving microvascular perfusion following percutaneous coronary intervention after myocardial infarction in hyperglycaemic patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Differential regulation of β2-adrenoceptor and adenosine A2B receptor signalling by GRK and arrestin proteins in arterial smooth muscle

Craig A. Nash, Carl P. Nelson, Rajendra Mistry, Christian Moeller-Olsen, Elena Christofidou, R. A. John Challiss, Jonathon M. Willets

CELLULAR SIGNALLING (2018)

Article Neurosciences

A novel form of glycolytic metabolism-dependent cardioprotection revealed by PKCα and β inhibition

Sean Brennan, Shen Chen, Samir Makwana, Christopher A. Martin, Mark W. Sims, Asma S. A. Alonazi, Jonathan M. Willets, Iain B. Squire, Richard D. Rainbow

JOURNAL OF PHYSIOLOGY-LONDON (2019)

Article Biochemistry & Molecular Biology

Kir6.2-D323 and SUR2A-Q1336: an intersubunit interaction pairing for allosteric information transfer in the KATP channel complex

Sean Brennan, Hussein N. Rubaiy, Saba Imanzadeh, Ruth Reid, David Lodwick, Robert I. Norman, Richard D. Rainbow

BIOCHEMICAL JOURNAL (2020)

Article Biochemistry & Molecular Biology

Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs

Sophie J. Bradley, Colin Molloy, Paulina Valuskova, Louis Dwomoh, Miriam Scarpa, Mario Rossi, Lisa Finlayson, Kjell A. Svensson, Eyassu Chernet, Vanessa N. Barth, Karolina Gherbi, David A. Sykes, Caroline A. Wilson, Rajendra Mistry, Patrick M. Sexton, Arthur Christopoulos, Adrian J. Mogg, Elizabeth M. Rosethorne, Shuzo Sakata, R. A. John Challiss, Lisa M. Broad, Andrew B. Tobin

NATURE CHEMICAL BIOLOGY (2020)

Article Pharmacology & Pharmacy

β1-adrenoceptor-stimulated lactate production in cultured astrocytes is predominantly glycogen-independent

Xianguo Jiang, John Challiss, Paul Glynn

BIOCHEMICAL PHARMACOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Pathophysiological insights into atrial fibrillation: revisiting the electrophysiological substrate, anatomical substrate, and possible insights from proteomics

Robert Bentley, Sunil Jit R. J. Logantha, Parveen Sharma, Richard R. Rainbow, Gregory Y. H. Lip

CARDIOVASCULAR RESEARCH (2021)

Article Pharmacology & Pharmacy

The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1

Gavin E. Morris, Matthew J. Denniff, Elisavet Karamanavi, Sarah A. Andrews, Renata B. Kostogrys, Vasiliki Bountziouka, Maryam Ghaderi-Najafabadi, Noor Shamkhi, George McConnell, Michael A. Kaiser, Laura Carleton, Christine Schofield, Thorsten Kessler, Richard D. Rainbow, Nilesh J. Samani, Thomas R. Webb

Summary: The study reveals a novel role for SVEP1 and the integrins alpha 4 beta 1 and alpha 9 beta 1 in reducing VSMC contractility. Inhibition of these proteins significantly enhances calcium levels in VSMCs and leads to increased vessel contraction, mediated via VGCCs, PKC, and Rho A/Rho kinase dependent mechanisms.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection

Sean Brennan, Simona Esposito, Muhammad I. M. Abdelaziz, Christopher A. A. Martin, Samir Makwana, Mark W. W. Sims, Iain B. B. Squire, Parveen Sharma, Amy E. E. Chadwick, Richard D. Rainbow

Summary: Hyperglycemia at the time of myocardial infarction has a negative impact on prognosis, regardless of prior diabetes diagnosis. Glucose is suggested to be the damaging factor. In ex vivo models, it was demonstrated that acutely elevated glucose has harmful effects that are PKC alpha/beta-dependent. Cardioprotection can be obtained by inhibiting PKC alpha/beta. Short pretreatments with high glucose revealed time-dependent glucose cardiotoxicity, and inhibition of PKC alpha/beta was studied as a potential mechanism to reverse the toxicity. In isolated non-diabetic rat cardiomyocytes, exposure to elevated glucose for more than 7.5 minutes led to cardiotoxicity, while exposure to metabolic inhibition following 5-minute high glucose showed time-dependent protection lasting around 15 minutes. This protection was further enhanced with PKC alpha/beta inhibition. Cardioprotection was measured by delayed contractile failure, K-ATP channel activation, improved contractile and Ca2+ transient recovery, and increased cell survival. Pre-ischemic treatment with high glucose in a whole-heart coronary ligation protocol also revealed the presence of protection with PKC alpha/beta inhibition. Selective PKC alpha/beta inhibition enhances cardioprotection, suggesting that glycaemic control with PKC inhibition may be a potential therapeutic strategy for myocardial infarction and elective cardiac surgery.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Biochemistry & Molecular Biology

Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling

James A. Roberts, Richard D. Rainbow, Parveen Sharma

Summary: Cardiovascular toxicity and diseases have a detrimental impact on morbidity and mortality. The dysregulation of the NRF2 transcription factor can lead to susceptibility to toxicity and subsequent tissue dysfunction in the cardiovascular system. Stimulation of the NRF2 signalling pathway has shown potential in alleviating cardiotoxicity and cardiovascular disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Slowly activating voltage-gated potassium current potentiation by ML277 is a novel cardioprotective intervention

Sean Brennan, Abrar I. M. Alnaimi, Lauren R. Mcguinness, Muhammad I. M. Abdelaziz, Robert A. Mckenzie, Sophie Draycott, Jacob Whitmore, Parveen Sharma, Richard D. Rainbow

Summary: Cardiovascular disease is a major cause of global deaths, with ischemic heart disease, including myocardial infarction, leading to 1.7 million deaths annually. The study demonstrates that ML277, a potassium current modulator, provides cardioprotection against ischemia by modifying action potential duration. In various models, ML277 improves contractile recovery, cell survival, and reduces infarct size, suggesting its therapeutic potential in acute coronary syndromes.

PNAS NEXUS (2023)

Article Biology

Deep-Channel uses deep neural networks to detect single-molecule events from patch-clamp data

Numan Celik, Fiona O'Brien, Sean Brennan, Richard D. Rainbow, Caroline Dart, Yalin Zheng, Frans Coenen, Richard Barrett-Jolley

COMMUNICATIONS BIOLOGY (2020)

No Data Available